November 3, 2016
Strides, Mylan settle Regulatory and General Claims on Agila transaction, Strides gets $30M
Strides and Mylan have agree to settle Regulatory and General Claims on Agila transaction.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Business
November 2, 2016
Allergan announces $10 B accelerated share repurchase, initiation of cash dividend in 2017
Allergan has completed its initial $5 billion in share repurchases under its previously announced share repurchase program…
November 2, 2016
Targovax CEO steps down, current CFO takes the role
Targovax CEO has stepped down, current CFO takes the role
November 2, 2016
Shire doubles third quarter revenues, operates with net loss in Q3
Shire doubles third quarter revenues, operates with net loss in Q3
November 1, 2016
Pfizer to discontinue two ongoing cardiovascular studies
Pfizer announced today the discontinuation of the global clinical development program for bococizumab…
November 1, 2016
Allergan closes down Tobira purchace
Allergan has completed the acquisition of Tobira Therapeutics
November 1, 2016
Advanced Oncotherapy sees board changes
Advanced Oncotherapy has announced that Lord David Evans has stepped down
October 31, 2016
French Genfit raises €78.5M, aims to invest in R&D
French Genfit has raised €78.5 million and invests in its R&D
October 31, 2016
Exclusive: EpiPen price hikes add millions to Pentagon costs
Mylan NV’s price hikes on EpiPens have added millions to U.S. Department of Defense spending…
October 28, 2016
Sanofi will accept epilepsy drug blame if court rules that way
Sanofi will accept any blame attributed to it by a court over the harmful effects…